These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 4082101)

  • 21. Congenital anti-thrombin III deficiency with mesenteric venous thrombosis--functional and immunological estimations.
    Dale BM; Naujalis J; Barber S
    Pathology; 1984 Oct; 16(4):424-30. PubMed ID: 6522108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin cofactor activities in a family with hereditary antithrombin III deficiency: evidence for a second heparin cofactor in human plasma.
    Griffith MJ; Carraway T; White GC; Dombrose FA
    Blood; 1983 Jan; 61(1):111-8. PubMed ID: 6184096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.
    de Moerloose PA; Reber G; Vernet P; Minazio P; Bouvier CA
    Thromb Haemost; 1987 Apr; 57(2):154-7. PubMed ID: 3603409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
    Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K
    Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hereditary abnormalities of antithrombin III in patients with recurrent thrombophlebitis].
    Bekić-Kaluza S; Rezaković D; Musa M
    Med Arh; 1986; 40(1-2):51-3. PubMed ID: 3272307
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antithrombin III deficiency and tendency to thrombosis (author's transl)].
    Lechner K; Thaler E; Niessner H; Nowotny C; Partsch H
    Wien Klin Wochenschr; 1977 Apr; 89(7):215-22. PubMed ID: 857429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and further characterization of antithrombin III Milano: lack of reactivity with thrombin.
    Wolf M; Boyer-Neumann C; Meyer D; Tripodi A; Mannucci PM; Larrieu MJ
    Thromb Haemost; 1987 Oct; 58(3):888-92. PubMed ID: 3433251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial deficiency of antithrombin III: evidence for heterogeneity existing within the family.
    d'Souza S; Ekert H
    Aust N Z J Med; 1984 Dec; 14(6):835-40. PubMed ID: 6598052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired antithrombin III deficiency: replacement with antithrombin III concentrates in a patient with protein S deficiency accelerates response to therapy.
    Humphries JE
    Acta Haematol; 1993; 90(3):151-4. PubMed ID: 8291376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombin III deficiency: decreased synthesis of a biochemically normal molecule.
    Ambruso DR; Leonard BD; Bies RD; Jacobson L; Hathaway WE; Reeve EB
    Blood; 1982 Jul; 60(1):78-83. PubMed ID: 7082848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal reactivity with thrombin of a new variant of dysfunctional antithrombin (AT 'Vicenza').
    Finazzi G; Barbui T; Tran TH; Duckert F
    Ric Clin Lab; 1984; 14(3):515-9. PubMed ID: 6522961
    [No Abstract]   [Full Text] [Related]  

  • 32. Antithrombin III Trento. A 'new' congenital AT III abnormality with a peculiar crossed-immunoelectrophoretic pattern in the absence of heparin.
    Girolami A; Marafioti F; Rubertelli M; Vicarioto MA; Cappellato G; Mazzuccato M
    Acta Haematol; 1984; 72(2):73-82. PubMed ID: 6208738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new familial variant of antithrombin III: 'antithrombin III Paris'.
    Wolf M; Boyer C; Lavergne JM; Larrieu MJ
    Br J Haematol; 1982 Jun; 51(2):285-95. PubMed ID: 7082587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration.
    Collen D; Schetz J; de Cock F; Holmer E; Verstraete M
    Eur J Clin Invest; 1977 Feb; 7(1):27-35. PubMed ID: 65284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thrombosis patients with familial antithrombin-III deficiency treated with heparin and antithrombin].
    Brandt P
    Ugeskr Laeger; 1981; 143(34):2145-8. PubMed ID: 7281335
    [No Abstract]   [Full Text] [Related]  

  • 36. Heterogeneity of the "classical" antithrombin III deficiency.
    Sas G; Petö I; Bánhegyi D; Blaskó G; Domján G
    Thromb Haemost; 1980 Jun; 43(2):133-6. PubMed ID: 7455972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification of antithrombin 'Vicenza': a molecule with normal heparin affinity and impaired reactivity to thrombin.
    Finazzi G; Tran TH; Barbui T; Duckert F
    Br J Haematol; 1985 Feb; 59(2):259-63. PubMed ID: 3970857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombin III Alger: a new homozygous AT III variant.
    Fischer AM; Cornu P; Sternberg C; Mériane F; Dautzenberg MD; Chafa O; Beguin S; Desnos M
    Thromb Haemost; 1986 Apr; 55(2):218-21. PubMed ID: 3715788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombin-III-Hamilton, Ala 382 to Thr: an antithrombin-III variant that acts as a substrate but not an inhibitor of alpha-thrombin and factor Xa.
    Austin RC; Rachubinski RA; Ofosu FA; Blajchman MA
    Blood; 1991 May; 77(10):2185-9. PubMed ID: 2029579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis.
    Okajima K; Abe H; Maeda S; Motomura M; Tsujihata M; Nagataki S; Okabe H; Takatsuki K
    Blood; 1993 Mar; 81(5):1300-5. PubMed ID: 8443391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.